Pre market evaluation refers to the series of assessments and tests conducted before a new cancer treatment or diagnostic tool can be made available to the public. This process ensures that the new intervention is both safe and effective. It encompasses a range of activities, including preclinical studies, clinical trials, and regulatory reviews.
